Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Frederick G. Vogt, J.D.,PhD$3.2B
Market Cap • 22/04/20242007
(há 17 anos)
2010
(14 years ago)
NASDAQ
Listagem
San Carlos
Sede • California503
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IOVASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.